FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/28/2026
Back to search
Official data from USPTO
ERELZI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/29/2026
Trademark type
Word
Nice classes
5
Filing date
10/15/2024
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
SPEAKE, WADE E
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Sandoz AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
27 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/14/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/10/2026
FIMP
FINAL DISPOSITION PROCESSED
05/10/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/27/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/28/2026
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2025
RFNT
REFUSAL PROCESSED BY IB
03/29/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2025
RFRR
REFUSAL PROCESSED BY MPU
03/10/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/22/2025
CNRT
NON-FINAL ACTION WRITTEN
01/21/2025
DOCK
ASSIGNED TO EXAMINER
01/10/2025
MAFR
APPLICATION FILING RECEIPT MAILED
12/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/04/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/28/2024
Continuous trademark protection
Get notified about every new filing that threatens ERELZI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.